Cleerly LABS vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Cleerly
VS
by RapidAI (formerly iSchemaView)

AI Verdict

Cleerly LABS is an AI tool focused on comprehensive analysis of coronary CT angiography (CCTA) to detect and characterize atherosclerosis and stenosis for personalized heart disease management. In contrast, Rapid RV/LV by RapidAI is designed for the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. While both are FDA-cleared AI solutions for cardiovascular imaging, they address distinct clinical conditions and utilize different types of CT scans.

Choose Cleerly LABS if…

Choose Cleerly LABS if your primary goal is a comprehensive, AI-powered assessment of coronary atherosclerosis and stenosis from CCTA scans. This tool is ideal for detailed plaque characterization, personalized heart disease risk assessment, and tracking disease progression over time to guide long-term management strategies for patients with suspected or known coronary artery disease.

View Cleerly LABS →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if you require rapid, automated assessment of pulmonary embolism severity in acute settings. This tool is best suited for emergency departments or critical care units where quickly obtaining objective right and left ventricle ratios from CTPA scans is essential for immediate patient triage and guiding urgent treatment decisions.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly LABS Rapid RV/LV
Pricing Varies Contact vendor for pricing information.
Deployment Cloud, On-premise On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Cleerly LABS is a web-based application, which generally offers broad accessibility and ease of use for clinicians, with web search confirming its integration into existing CCTA workflows. Rapid RV/LV, while offering on-premises/hybrid deployment, is praised for its speed and automated measurements that streamline emergency workflows, reducing manual effort. Both are designed to simplify complex tasks within their respective clinical contexts.

Clinical Value

Cleerly LABS

Cleerly LABS offers a comprehensive and longitudinal assessment of cardiovascular health by providing detailed plaque characterization, stenosis detection, and ischemia detection, aiding in personalized heart disease management and tracking progression over time. Rapid RV/LV provides rapid, objective assessment of pulmonary embolism severity, which is critical for acute care, but Cleerly's broader, proactive approach to disease management offers a deeper and more sustained clinical impact.

Pricing & Value

Cleerly LABS

Cleerly LABS provides transparent pricing information, including a retail price and a discounted offer, allowing for a clearer understanding of potential costs. In contrast, Rapid RV/LV requires users to contact the vendor for pricing details, making it difficult to assess its value proposition without direct engagement.

Enterprise Readiness

Tie

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), demonstrating strong foundational enterprise readiness. Cleerly LABS is cloud-based with an on-site proxy for data transfer and integrates with PACS, RIS, and EHR, while Rapid RV/LV offers on-premises or hybrid deployment with integration into its broader Rapid PE solution and triage capabilities. Both deployment models and integration strategies cater to different enterprise IT preferences and needs.

Innovation

Cleerly LABS

Cleerly LABS demonstrates a higher degree of innovation by focusing on comprehensive AI-powered CCTA analysis for detailed plaque characterization and personalized risk assessment, aiming to redefine heart attack prevention by moving beyond traditional stenosis assessment. Rapid RV/LV, while innovative in its rapid automation of RV/LV ratio measurement for acute PE severity, addresses a more specific diagnostic need rather than a paradigm shift in long-term disease management.

Support & Docs

Rapid RV/LV

RapidAI explicitly states it offers 24/7/365 customer support via email and phone for its critical care solutions, indicating a robust and readily available support system. While Cleerly also provides customer support, training, and technical assistance, its stated support hours are Monday through Friday, 10 am ET to 6 pm ET, with after-hours needs as a first priority, which is less comprehensive than RapidAI's round-the-clock availability.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly LABS Rapid RV/LV
Tool Name Cleerly LABS Rapid RV/LV
Company Cleerly RapidAI (formerly iSchemaView)
Primary Clinical Focus Comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Core AI Functionality AI-powered CCTA image analysis for comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, ischemia detection (with Cleerly ISCHEMIA module), 3D visualization, personalized heart disease risk assessment, tracking disease progression. AI-powered analysis of CTPA images for automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, rapid results, reduces inter-rater variability.
Target Imaging Modality Coronary CT angiography (CCTA) CTPA scans
Specialties Cardiology, Radiology Cardiology, Pulmonology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Cleerly LABS and Rapid RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly LABS is an AI-powered, FDA-cleared web-based software for comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, aiding in personalized heart disease management. Rapid RV/LV is an FDA-cleared AI tool for rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Cleerly LABS analyzes coronary CT angiography (CCTA) images. Rapid RV/LV analyzes CT pulmonary angiography (CTPA) scans.
Cleerly LABS provides comprehensive coronary plaque assessment (volume, type), stenosis detection and quantification, and can detect ischemia with its Cleerly ISCHEMIA module. Rapid RV/LV automatically measures right and left ventricle diameters and calculates the RV/LV ratio from CTPA images.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.